Group One Trading
PGNX

Group One Trading’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Group One Trading’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-18,000
Closed -$68K – 6471
2020
Q1 		$68K Sell
18,000
-22,200
-55% -$95.6K ﹤0.01% 3546
2019
Q4 		$205K Buy
40,200
+5,200
+15% +$27.5K ﹤0.01% 3154
2019
Q3 		$177K Sell
35,000
-7,300
-17% -$36.4K ﹤0.01% 3172
2019
Q2 		$261K Buy
42,300
+21,000
+99% +$101K ﹤0.01% 2656
2019
Q1 		$99K Sell
21,300
-47,600
-69% -$215K ﹤0.01% 3187
2018
Q4 		$289K Sell
68,900
-34,600
-33% -$176K ﹤0.01% 2403
2018
Q3 		$649K Sell
103,500
-20,900
-17% -$161K 0.01% 2058
2018
Q2 		$1M Sell
124,400
-41,300
-25% -$315K 0.01% 1727
2018
Q1 		$1.24M Buy
165,700
+142,700
+620% +$949K 0.01% 1347
2017
Q4 		$137K Buy
23,000
+6,400
+39% +$38.9K ﹤0.01% 3172
2017
Q3 		$122K Buy
16,600
+6,400
+63% +$40.7K ﹤0.01% 3106
2017
Q2 		$69K Sell
10,200
-83,800
-89% -$619K ﹤0.01% 3335
2017
Q1 		$887K Buy
94,000
+57,200
+155% +$571K 0.01% 1419
2016
Q4 		$318K Sell
36,800
-10,600
-22% -$78.3K ﹤0.01% 2081
2016
Q3 		$300K Buy
47,400
+30,300
+177% +$183K ﹤0.01% 2190
2016
Q2 		$72K Buy
+17,100
New +$82.6K ﹤0.01% 3076
2016
Q1 		– Sell
-17,400
Closed -$107K – 5178
2015
Q4 		$107K Sell
17,400
-12,400
-42% -$81.3K ﹤0.01% 2935
2015
Q3 		$170K Buy
29,800
+5,900
+25% +$45.3K ﹤0.01% 2639
2015
Q2 		$178K Sell
23,900
-5,100
-18% -$30.9K ﹤0.01% 2613
2015
Q1 		$173K Sell
29,000
-6,900
-19% -$43.4K ﹤0.01% 2497
2014
Q4 		$271K Buy
35,900
+14,700
+69% +$88K ﹤0.01% 2048
2014
Q3 		$110K Sell
21,200
-6,700
-24% -$33.4K ﹤0.01% 2898
2014
Q2 		$120K Sell
27,900
-12,200
-30% -$46.6K ﹤0.01% 2814
2014
Q1 		$164K Buy
40,100
+9,000
+29% +$46K ﹤0.01% 2617
2013
Q4 		$166K Buy
31,100
+29,400
+1,729% +$129K ﹤0.01% 2600
2013
Q3 		$9K Buy
1,700
+200
+13% +$1.08K ﹤0.01% 4540
2013
Q2 		$7K Buy
+1,500
New +$6.73K ﹤0.01% 4596

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Group One Trading's PGNX Position: Q2 2020 in Review

Group One Trading sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 9,478 shares — an estimated $36K sold.

Group One Trading first reported a position in PGNX in Q2 2013 and held it in 20 quarters. The position peaked at $511K in Q2 2018. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Group One Trading reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Group One Trading sold 9,478 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $36K.
  • Group One Trading first reported a position in Progenics Pharmaceuticals Inc in Q2 2013 and held it in 20 quarters.
  • Group One Trading's Progenics Pharmaceuticals Inc position peaked at $511K in Q2 2018.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Group One Trading's 13F filing for Q2 2020, filed 13 Aug 2020.